Heron Therapeutics
HRTX
HRTX
104 hedge funds and large institutions have $1.02B invested in Heron Therapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more capital invested
Capital invested by funds: $964M → $1.02B (+$59.8M)
0% more funds holding
Funds holding: 104 → 104 (0)
12.53% less ownership
Funds ownership: 129.64% → 117.12% (-13%)
Holders
104
Holding in Top 10
6
Calls
$12.1M
Puts
$1.58M
Top Buyers
| 1 | +$5.33M | |
| 2 | +$3.25M | |
| 3 | +$3.23M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.96M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.95M |
Top Sellers
| 1 | -$46.3M | |
| 2 | -$18.1M | |
| 3 | -$15.5M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$11.8M |
| 5 |
Citigroup
New York
|
-$5.36M |